![PE134010: β-GalNAc-PEG3-Azide label-new HCl / N-[2-Butyl-3-[4-[3-(butylamino)propoxybenzoyl]-5-benzofuranyl]-methanesulfonamide-d6 Hydrochloride](https://cdn.shopify.com/s/files/1/0810/4889/5786/files/PE134010-R_f8bae31b-2c31-46c0-8ea1-611f9226bf78.svg?v=1700577073)
Pay in 4 interest-free payments of $56.25 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
HCl / N-[2-Butyl-3-[4-[3-(butylamino)propoxybenzoyl]-5-benzofuranyl]-methanesulfonamide-d6 Hydrochloride
the target of abundant naturally occurring human anti-Gal antibodies and central to xenotransplantation and anti-Gal immunology research
13 / HHV1-gB(UniProt ID P08665) synthetic glycopeptide HSV1-gB fragment (Gly50-Pro56
This compound provides a lactose (Galβ1-4Glc) building block for glycoconjugate synthesis and the construction of probes for galactose-recognizing proteins
4-dideoxy-4-fluoro-D-glucopyranose (mixed anomers)
PE134010: β-GalNAc-PEG3-Azide label-new HCl / N-[2-Butyl-3-[4-[3-(butylamino)propoxybenzoyl]-5-benzofuranyl]-methanesulfonamide-d6 HydrochlorideC14H26N4O9 378. 38 A D N acetylgalactosamine (GalNAc) ligand equipped with an azide handle through a hydrophilic PEG3 spacer. The terminal azide couples to alkynes via copper catalyzed azide alkyne cycloaddition (CuAAC) or to DBCO and related strained alkynes via copper free click chemistry, forming stable 1,2,3 triazole linkages. This compound enables the construction of hepatocyte targeted therapeutics and research tools that exploit the
![Leatt 4.5/5.5 Footbed - Red [Pair] size:8](https://cdn.shopify.com/s/files/1/0725/9026/2516/files/LE3020002180.jpg?v=1780020058)
